Antidyskinetic actions of amantadine in Parkinson’s disease: are benefits maintained in the long term?

Newsletter

Get the latest science from Atuka

Sign up to receive our quarterly newsletter featuring the latest developments in Parkinson’s disease research.

List Signup

Talk to our experts

Advance your therapeutic program